4//SEC Filing
MacPhee John A 4
Accession 0001209191-20-034779
CIK 0001328143other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:12 PM ET
Size
10.7 KB
Accession
0001209191-20-034779
Insider Transaction Report
Form 4
MacPhee John A
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-03+10,000→ 10,000 totalExercise: $2.70Exp: 2030-06-02→ Common Stock (10,000 underlying) - Award
Common Stock
2020-06-03+5,000→ 5,000 total
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest on the date 1 year from June 3, 2020, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.
- [F2]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 3, 2020, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001339976
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:12 PM ET
- Size
- 10.7 KB